Lionel K.
- Country
- France
- Department
- Service d'Hematologie Clinique
Research Overview
- Phase II Study of Quadruplet Induction and Consolidation with Tandem Autologous Stem Cell Transplantation in Newly Diagnosed High-Risk Multiple Myeloma
- Pharmacokinetic Comparability Study of Pre- and Post-change Teclistamab in Relapsed/Refractory Multiple Myeloma Patients
- Dose Optimization and Safety Evaluation of ABBV-383 in Patients with Relapsed or Refractory Multiple Myeloma
Data & Insights
Has run more than one trial at 301 of 439 partner sites.
Specializations
Multiple Myeloma Treatment
Specializes in innovative therapeutic approaches for multiple myeloma, with particular focus on novel drug combinations and immunotherapy strategies. Lead investigator in studies examining both newly diagnosed and relapsed/refractory cases.
- Novel Combination Therapies
- Immunotherapy Approaches
- CAR T-Cell Treatments
Blood Cancer Innovations
Conducts research in plasma cell disorders, including AL amyloidosis and plasma cell leukemia. Investigates targeted therapies and their applications across various blood cancers.
- Targeted Therapeutic Approaches
- Monoclonal Antibody Treatments
- Drug Resistance Studies
Treatment Optimization
Focuses on optimizing treatment strategies through minimal residual disease monitoring and development of maintenance therapies. Explores both subcutaneous and intravenous administration routes for various therapeutics.
- Disease Monitoring Techniques
- Drug Administration Methods
- Long-term Treatment Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.